Home > Healthcare > Medical Devices > Therapeutic Devices > Kyphoplasty Market

Kyphoplasty Market Analysis

  • Report ID: GMI6206
  • Published Date: Jul 2023
  • Report Format: PDF

Kyphoplasty Market Analysis

Based on product, the kyphoplasty market is bifurcated into balloon catheters, bone access devices, bone cement, cement mixing systems, and instruments. The bone access devices segment held the largest revenue share accounting for USD 236.7 million in 2022. The increasing incidence rate of vertebral compression fractures often associated with osteoporosis and spinal tumors will drive the demand for bone access devices as the awareness and diagnosis of these conditions improve, the need for effective bone access devices to perform kyphoplasty procedures also increases.

 

Moreover, the increasing demand for minimally invasive procedures in the field of spine surgery will spur the need for specialized bone access devices. These devices enable surgeons to create small incisions and access the fractured vertebrae with minimal tissue disruption, reducing patient trauma, postoperative pain, and recovery time thereby accelerating segmental revenue growth.
 

Global Kyphoplasty Market Share, By Application, 2022

Based on application, the kyphoplasty market is classified into vertebral alignment restoration, spinal fractures, and kyphosis. The spinal fractures segment dominated the market and is anticipated to witness over USD 590 million by 2032. Rising rates of compressed spine bones owing to malignancy and trauma will propel the market expansion capabilities. Additionally, the global increase in the aging population base plays a significant role in driving the spinal fractures segment as older individuals are more susceptible to conditions such as osteoporosis that leads to vertebral fractures.
 

Based on indication, the kyphoplasty market is segmented into osteoporosis and others. The osteoporosis segment held the largest revenue size over USD 411 million in 2022 and is estimated to witness significant growth over the forecasted period. The high segment growth is owing to the rising incidence and prevalence of osteoporosis along with an upsurge in geriatric population base. The burden of osteoporosis-related fractures, including vertebral fractures, on patients and healthcare systems is a driving factor for the osteoporosis segment. The clinical requirement for effective therapies for osteoporotic fractures has pushed demand for kyphoplasty operations, resulting in the osteoporosis segment's market domination.
 

The kyphoplasty market is segmented by end-use into hospitals & clinics, ambulatory surgical centers, and others. Hospitals & clinics segment dominated the global market accounting for 68.4% business share in 2022. The high segment growth is attributable to the strong availability and accessibility of advanced medical imaging devices for surgical interventions coupled with the presence of healthcare professionals. Further, hospitals offer minimally invasive procedures like kyphoplasty to enhance patient satisfaction will attract a larger patient population base thereby, witnessing a spike in the revenue stream. Moreover, favourable reimbursement policies and insurance coverage for kyphoplasty procedures among settings will contribute considerably towards the adoption of kyphoplasty in hospitals & clinics thereby leading to segment growth.
 

 U.S. Kyphoplasty Market Size,

Moreover, the preference for minimally invasive procedures in the U.S. is another major aspect propelling the market growth. The minimally invasive kyphoplasty techniques offers several advantages such as smaller incisions, reduced tissue trauma, shorter hospital stays, and faster recovery compared to traditional open surgery thereby bolstering market demand. Furthermore, the strong presence of business players, favourable reimbursement policies and insurance coverage are few other aspects boosting market progression in near future.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

The global market for kyphoplasty was valued at USD 635 million in 2022 and is estimated to account for USD 1.1 billion by 2032, owing to growing prevalence of osteoporosis.

The bone access devices segment accounted for USD 236.7 million in 2022, backed by the increasing demand for minimally invasive procedures in the field of spine surgery.

The U.S. kyphoplasty market was worth USD 260.7 million in 2022 and is predicted to witness substantial growth through 2032, on account of increasing elderly populace that is more prone to conditions such as osteoporosis and vertebral fractures.

Stryker, MicroPort Scientific Corporation, Medtronic Inc., DePuy Synthes (Johnson & Johnson Services Inc.), Smith & Nephew, IZI Medical Products, Merit Medical Systems, CareFusion, Joimax GmbH, Joline GmbH & Co. KG, G21 S.r.l., among others.

Kyphoplasty Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 16
  • Tables & Figures: 445
  • Countries covered: 30
  • Pages: 328
 Download Free Sample